pause

The high-stakes nomination of Todd Blanche to be attorney general has turned into a clash of wills between President Trump and two Senate Republicans whose political careers he claims credit for ending.

After a vote on Blanche’s nomination was delayed over concerns raised by two lame-duck Republican senators, the president said Thursday he might put Blanche’s nomination on hold rather than meet their demands.

Sen. John Cornyn (R-Texas) and Sen. Thom Tillis (R-NC) have indicated that they will vote to support advancing Blanche’s nomination only if the Justice Department provides written assurance that it has completely abandoned a controversial $1.8-billion “anti-weaponization” fund created as part of a settlement between Trump and the Internal Revenue Service and will limit the scope of tax audit immunity granted to Trump, his sons and a business.

Those provisions were part of a proposed settlement of a $10-billion lawsuit Trump filed against the IRS, which is part of his administration.

“The opposition to such a high-ranking executive branch nomination from within Republican ranks is quite unprecedented,” said Phil Brest, who was a top Democratic staffer for the Senate Judiciary Committee during the nominations of Jeff Sessions, Bill Barr and Merrick Garland, who each served as attorney general.

The Senate careers of both Cornyn and TIllis are coming to an end this year after Trump declined to endorse them.

“John Cornyn, of Texas, and Thom Tillis, of North Carolina, both of whom I refused to Endorse, and whose political careers have been ended by my action, are refusing to vote for this Great Nominee,” Trump wrote on Truth Social, his social media platform. “I have no objection to temporarily withdrawing Todd’s name, if they do not do the right thing, and putting him back after Cornyn and Tillis are out of office.”

But that decision brings about its own political risk.

With the president’s approval rating sitting below 35% in recent polls, Democrats could shrink or even reverse the Republican Party’s current 53-seat Senate majority this November. Cornyn‘s and Tillis’ seats in Texas and North Carolina are both at risk of flipping to Democrats.

“So waiting until 2027 could be far harder than it is right now,” said Jessica Taylor, the Senate and governors editor at the nonpartisan Cook Political Report.

Blanche has been serving as acting attorney general since Atty. Gen Pam Bondi was fired in April. He was previously the deputy attorney general and has been associated with some of the most controversial policies associated with the Trump administration, including the IRS settlement, the handling of the Epstein files and prosecutions of Trump’s perceived enemies.

Blanche can continue in the acting role even if he is not confirmed, but the Trump administration would be blocked from appointing a new deputy attorney general unless he is confirmed.

Sen. Chuck Grassley (R-Iowa), chair of the Senate Judiciary Committee, which is vetting Blanche, told reporters Thursday that he is hoping to keep Blanche’s nomination on track.

“I’m going to work real hard the next few days to get this thing settled. That’s what we’re going to do. I’m not going to consider any other option, because there’s no reason to consider other options at this point,” Grassley said.

Because the Senate is scheduled to begin its five-week August recess at the end of next week, Blanche probably wouldn’t come before the full Senate for a vote until September at the earliest if the nomination advances out of the Judiciary Committee.

That would put the vote squarely in the middle of peak campaign season, which could present vulnerable Republicans such as Sen. Susan Collins of Maine and Sen. Dan Sullivan of Alaska with a difficult vote on a nominee who has been linked to many of the Trump administration’s most polarizing policies.

A vote against Blanche could incur the wrath of Trump, while a vote for him could turn off moderate voters.

“It’s a Catch-22 for a lot of these candidates. They still need Trump’s voters to come out, but they still need a swing vote as well,” Taylor said.

Blanche worked earlier in his career as a federal prosecutor in New York but was more recently Trump’s criminal defense attorney in the lead-up to his second term in the White House.

Blanche faced questions about his independence from his former client throughout his nomination hearing earlier this month. But his answer to one seemingly friendly question, about whether he and Trump are friends, might have inadvertently hurt his case.

“I’m his lawyer,” Blanche replied, before correcting himself. “Was his lawyer.”

The Judiciary Committee currently has 12 Republicans and 10 Democrats. With all 10 Democrats firmly in opposition to Blanche, a vote against moving forward by Cornyn or Tillis would probably put an end to the nomination.

This isn’t the first time Tillis has wielded his political leverage during a high-stakes nomination process.

He briefly blocked the nomination of Federal Reserve Chairman Kevin Warsh until the Justice Department dropped a lawsuit against outgoing Federal Reserve Chair Jerome Powell.

“Sen. Tillis has been unafraid to use his vote to extract concessions from the Trump administration,” said Brest, who is now president of the American Constitution Society, a progressive legal nonprofit. “There’s a playbook for this and he has been effective with that playbook.”

The US military says it has successfully intercepted a barrage of missiles fired by Iran at its troops in Jordan. The sudden attack coincides with Israeli Prime Minister Benjamin Netanyahu’s visit to the White House and comes after a five-day pause in the war. Al Jazeera’s Resul Serdar reports from Tehran.

US President Donald Trump says talks with Iran are continuing during a pause in US military strikes, adding he believes there is ‘a good chance’ of a breakthrough but warning military action could resume if negotiations fail.

Though ostensibly aimed at giving diplomacy another shot at ending the conflict with Iran, the Trump administration’s pause in attacking the Islamic Republic reportedly comes as concerns linger over the supply of munitions, especially air defense interceptors. It is a notion that the president again dismissed on Monday; however, the lack of sufficient magazine depth is an issue that TWZ has raised frequently for years, and especially in regard to America’s air and missile defenses, in particular. In fact, we laid out in detail these exact concerns and how they would be a major issue in war with Iran just prior to the conflict starting in a feature you can read in full here. Meanwhile, amid the lull in fighting between the U.S. and Iran, Saudi Arabia and Jordan say they are still being attacked.

The U.S. and Iran stopped firing at each other late last week, leading to a pause after 13 straight days of continuous tit-for-tat operations. There hasn’t been a U.S. strike on Iranian territory since last Thursday. On Monday, President Donald Trump claims the U.S. has sufficient weapons stockpiles.

“…we have a lot,” Trump proclaimed to reporters aboard Air Force One when asked if he is concerned about a shortage of high-end munitions like interceptors for Patriot and Terminal High Altitude Area Defense (THAAD) systems. “We have a lot of the mid-level stuff too. Maybe more than we could ever use, no matter what. But we have a lot. I’d like to have more, to be honest.”

After again blaming the Biden administration for giving away too many weapons to Ukraine, Trump said the U.S. is restocking.

“So we’re building it very rapidly,” he exclaimed. “Plants are being built. A lot of equipment’s being built. The Patriots, in particular, are being built. That system is going up. We have a lot. Every one of our contractors is building four to five plants right now, and we’re in very good shape. But for some of the more sophisticated stuff, we certainly like that part.”

Before Trump spoke, the Pentagon on Monday announced that it signed “two landmark seven-year framework agreements” with Lockheed Martin and L3Harris “to expand production capacity for key components of the Patriot Advanced Capability-3 (PAC-3) Missile Segment Enhancement (MSE) interceptor and the Terminal High Altitude Area Defense (THAAD) weapon system.”

“Under this agreement, L3Harris will accelerate the production of its advanced two-pulse solid rocket motor, Attitude Control Motors, and the Lethality Enhancer,” the Pentagon said in a media release. “The motors deliver the critical speed, extended range, and precise maneuverability the PAC-3 MSE needs to defeat advanced tactical ballistic missiles, cruise missiles, and enemy aircraft.”

Concurrently, “the THAAD interceptor propulsion agreement, signed by the DoW, L3Harris, and Lockheed Martin, will expand manufacturing of two critical components: the solid rocket boost motor that launches the interceptor and the highly responsive Liquid Divert and Attitude Control System (LDACS),” the Pentagon added. “The LDACS provides the vital in-flight maneuverability required to engage and neutralize ballistic missile threats both inside and outside Earth’s atmosphere.”

As we have noted in previous reporting, current production PAC-3 MSE “is around the baseline rate of 650 interceptors per year, with half the deliveries going to the United States and the rest to allies and partners,” CSIS postulated in a May report about the severity of the depletion of U.S. offensive and defensive weapons during the 39 days of Epic Fury. 

Under a contract with the Pentagon inked in January, Lockheed is committed to boosting Patriot annual production to 2,000.

Still, the supply of these weapons remains a major issue.

The Wall Street Journal on Sunday reported that questions about the supply of U.S. offensive and defensive weapons are a large factor in the Trump administration’s reasons for halting attacks on Iran.

“The U.S. military had been poised Friday to launch an intensive series of strikes against Iran, which could have lasted up to two weeks,” the Journal noted, citing officials.

But the operation was delayed “so diplomacy could proceed and as officials discussed the effect a major attack could have on the U.S.’s shrinking stocks of Patriot and other air defense interceptors,” the publication added. “The president could still order an attack, officials said, noting that the situation remains fluid.”

The White House “has been informed of the declining inventories of air defense interceptors by Gen. Dan Caine, the chairman of the Joint Chiefs of Staff,” the publication continued. “The issue is a concern for Caine, who believes that the low inventories wouldn’t preclude a resumption of major combat operations against Iran, but would add to the risk.”

Several officials said Adm. Brad Cooper, who leads U.S. Central Command (CENTCOM), “believes the U.S. can cope with the limited stocks of Patriot and other air defense interceptors because stepped-up U.S. strikes, if they are approved by Trump, would blunt Iran’s ability to launch large numbers of missiles.”

We reached out to CENTCOM for comment.

Questions about American stocks of high-end weapons also extend to Europe and Asia.

“U.S. officials now worry that President Vladimir V. Putin of Russia and Xi Jinping of China could be factoring the shortages into calculations of their next moves, in Ukraine and Europe for Mr. Putin and perhaps against Taiwan for Mr. Xi,” The New York Times posited on Sunday.

Trump also claimed that the Iranians are eager to reach a peace accord.

Iranian leaders requested a meeting and “the only reason they want to meet is because we’ve been hitting them very hard,” Trump told reporters.

Asked how much patience he has for negotiations, he said: “I have a lot of patience.”

“We’ll see what happens,” the president added. “I think there is a good chance that something could happen. If it doesn’t, we go back to doing what we were doing two days ago.”

Officials in Tehran scoffed at Trump’s assertion, saying there are no direct negotiations taking place.

The American leader also dismissed an assertion by Ukrainian President Volodymy Zelensky that Russia was providing Iran with satellite imagery used to help Iran strike U.S. an allied targets in the Middle East.

“We’ll find out if that’s true,” Trump told reporters. “I’ll ask Putin about it. It hasn’t had much impact, because we knocked the hell out of them.”

The US has paused its two-week bombing campaign against Iran, prompting Tehran to suspend its regional retaliatory attacks.

The delay, filed in court on Friday, can cost Paramount $1.7bn in fees if the deal is not closed by next June.

Paramount Skydance has agreed to pause its $110bn acquisition of Warner Bros Discovery until after a federal judge rules on states’ challenge to the deal, according to court papers.

The delay, filed in court on Friday, could cost Paramount Skydance about $7m a day in fees it agreed to pay Warner Bros shareholders if the merger does not close by September 30.

“We look forward to proving our case at trial,” Paramount’s spokesperson said.

Twelve states, led by California, sued on July 13, arguing the deal would “extinguish competition” in Hollywood and lead to fewer choices for consumers, particularly moviegoers and cable customers. Paramount has called the states’ claims meritless and pledged to “vigorously defend” its merger.

“Halting this merger while our case proceeds is a critical victory in our efforts to uphold the law and protect the film and television industries,” said New York Attorney General Letitia James, who is suing to block the deal.

Friday’s move arrives just days after US District Judge Araceli Martinez-Olguin granted a temporary restraining order requested by the states to freeze the transaction for several weeks.

The companies agreed to pause the deal until five days after the judge rules on the merits of the case, or June 1, 2027, whichever comes first. Paramount could owe as much as $1.7bn in ticking fees to Warner Bros shareholders if the deal is delayed until then.

Similar merger challenges have taken an average of eight months for a judge to rule, a review of recent cases by the Reuters news agency has found.

There have also been concerns over a media stranglehold as the merger would have brought CNN, currently owned by Warner Bros, under the umbrella of Paramount. The latter already owns CBS, which has seen a fair amount of turmoil amid allegations of bias in favour of US President Donald Trump under the leadership of CEO David Ellison, whose father, tech billionaire Larry Ellison, is a Trump ally.

Eurostat’s final figures, published on Friday, showed annual inflation easing from 3.2% in May to 2.8% in June, the first decline since prices began accelerating in January, less than a week before the ECB’s Governing Council announces its policy decision on Thursday and decides whether June’s first interest-rate hike in nearly three years should be followed by another increase.

ADVERTISEMENT

ADVERTISEMENT

The details of the release lean towards a pause.

Core inflation, which strips out energy, food, alcohol and tobacco, slowed from 2.6% to 2.4%, energy inflation cooled from 10.8% to 8.5% and services eased from 3.5% to 3.2%, with the headline rate falling in 22 of the EU’s 27 member states.

Among the eurozone’s big four economies, Germany stood at 2.4%, France at 2%, Italy at 3% and Spain at 3.6%.

The numbers matter because of what came before.

In June, the ECB lifted its deposit facility rate from 2% to 2.25%, its first increase in nearly three years, after the war in Iran drove eurozone inflation to 3.2% in May, the highest reading since September 2023.

A reignited Iran war

The complication is that the shock behind that hike has returned.

Oil neared $120 a barrel in March before sliding to around $72 following an interim peace agreement at the end of June, but the truce has frayed badly this month.

The US and Iran have exchanged fresh strikes, Tehran has attacked ships and threatened regional energy exports, and Washington has reimposed sanctions and stepped up its naval blockade, pushing Brent crude back up to $87 a barrel on Friday.

That resurgence has revived the possibility of a surprise hike on Thursday, according to ING, although the bank still expects a hold, with a second increase more realistic in September.

Renewed conflict involving Iran

The complication is that the shock behind that June rate hike has returned.

Oil prices neared $120 a barrel in March before sliding to around $72 following an interim peace agreement at the end of June. However, the truce has frayed badly this month.

The United States and Iran have exchanged fresh strikes, Tehran has attacked commercial shipping and threatened regional energy exports, while Washington has reimposed sanctions and tightened its naval blockade, pushing Brent crude back up to $87 a barrel on Friday.

The renewed escalation has revived the possibility of a surprise rate hike on Thursday, according to ING, although the bank still expects the ECB to hold rates steady, viewing a second increase as more likely in September.

July is also not a forecasting meeting, giving policymakers cover to wait for updated economic projections before taking further action.

What Lagarde has signalled

Speaking at the ECB’s Sintra forum a few weeks ago, ECB President Christine Lagarde insisted June’s rate hike was not an “insurance hike” but a response to a genuine inflation problem. She noted that the ECB’s projections showed inflation returning to its 2% target only in late 2027, and only if monetary policy was tightened further.

Lagarde also refused to pre-commit to a policy path, saying “forward guidance is not in the cards” and that decisions would continue to be made on a meeting-by-meeting basis, guided by incoming economic data.

The ECB remains the only major Western central bank to have actually pulled the trigger.

The US Federal Reserve left its benchmark interest rate unchanged at 3.50%-3.75% in June, at Kevin Warsh’s first meeting as chair, although his hawkish tone unsettled markets.

The Bank of England also left its Bank Rate unchanged at 3.75% in a 7-2 vote, with two policymakers preferring an increase to 4.0%, while the Bank of Japan raised its policy rate to a 31-year high of 1.0%.

Anthropic is proposing that the world’s top artificial intelligence companies come up with a coordinated way to pause development of advanced AI systems, warning that the technology is improving so quickly that there’s a risk humans would lose control.

The company behind the Claude chatbot said in a blog post on Thursday that, as cutting-edge AI gets increasingly faster at carrying out tasks, “it would be good for the world to have the option to slow or temporarily pause” its development.

Anthropic said its internal research institute plans to explore the issue in collaboration with others and “take actions” to help build the systems for a credible slowdown or pause, without being more specific.

Anthropic rival OpenAI argued for a different approach in a report published on Wednesday, saying that “democratic governments — not private companies acting alone — must ultimately determine the rules, safeguards, and accountability mechanisms”.

“Our view is that decisions about the pace of AI innovation should not be left to any one lab, company, or special interest group,” it said.

AI models are getting faster, with rapid increases in how quickly they can carry out software tasks like coding on their own, Anthropic said in its post. Based on current trends and given enough computing power, an AI system could be able to design and develop its own successor, in what is known as “recursive self-improvement”.

Self-building AI would be a major technological milestone that would bring benefits in science, healthcare and other areas, Anthropic said, but it “also might increase the risks of humans losing control over AI systems”.

Some tech industry figures have long warned of such a scenario.

Anthropic’s post comes after a different warning this week from a team of researchers at the University of Toronto who showed how AI tools could be used to create a new kind of AI “worm” that adapts its hacking strategy as it spreads from device to device and takes over a vast computing network.

“I think it’s really important that people understand that it’s not just the biggest, most powerful language models that pose the security concerns,” lead researcher Nicolas Papernot said in an interview.

The authors of the Anthropic post, company cofounder Jack Clark and Marina Favaro, head of its research institute, said the pause would be used to enable “societal structures and alignment research” to keep up with AI advances. Alignment is industry shorthand for making sure the technology matches human values and intentions.

The proposed coordination would let advanced AI labs verify that global rivals have actually stopped or slowed their work, “and that a bad actor could not use the auspices of a coordinated slowdown to jump ahead in secret”.

The company said a coordinated global mechanism is needed because, without it, a slowdown in AI development could let the “least cautious” players catch up and add to pressure on companies and governments as they make tough choices about AI safety.

Fears that advanced AI systems may get out of human control and cause societal harm have risen as the technology becomes increasingly capable. Anthropic’s own Mythos model sent shockwaves through industries, including banking and software, earlier this year with its ability to find vulnerabilities in existing code.

But regulation has been slow, especially in the US, where most leading AI labs are based. A Trump administration executive order earlier this week put the onus on the labs themselves, asking them to voluntarily submit their most capable models for government cybersecurity testing before public release.

Safety focus

AI researchers have also urged a pause before, but have had little success. Elon Musk, who owns AI lab xAI, was among the backers of a 2023 push by the non-profit Future of Life Institute to halt AI development for six months to allow time for safety guardrails.

Anthropic has long positioned itself as a safety-focused AI lab. Earlier this year, it refused to let the US military use its models for domestic surveillance and fully autonomous weapons, prompting backlash from the government, which put it on a national security blacklist, set to take effect later in 2026.

Anthropic’s post comes as the company and ChatGPT-maker OpenAI race to sell shares on the stock market, in an IPO that could value Anthropic at nearly a trillion dollars.

Papernot notified Canadian cybersecurity authorities prior to releasing his report, which shows how researchers developed the worm in a laboratory by using an “open-source” AI tool that is easy for software developers to cheaply access and modify.

“In the past, cyber attackers would focus on targets that are very high value,” he said. “Banking systems, hospitals, electricity grids, water treatment systems, schools.”

Papernot agreed that there should be more collaboration between companies, government agencies and academic researchers to develop countermeasures as AI-powered hacking tools supercharge the search for computer vulnerabilities.

“That old laptop you have in your basement that you don’t check on regularly doesn’t seem like a very high-value target, but it can be used as a launch pad to attack these higher-value targets,” he said. “Anything connected to the internet is now at risk because of how low the cost has become to mount these cyberattacks.”

May 2 (UPI) — A company that makes the abortion drug mifepristone on Saturday asked the U.S. Supreme Court to immediately pause a ruling that prevents doctors from prescribing it during telehealth visits.

Late Friday, a three judge panel on the 5th Circuit Court of Appeals unanimously ruled in favor of the state of Louisiana in a case asking the court to block doctors from prescribing the drug in telehealth visits.

Louisiana in the last four years has moved to prevent women in the state from obtaining abortion care legislators there were among the first to ban abortion after the repeal of Roe v. Wade, and later blocked doctors from prescribing the medical abortion pill in virtual telehealth visits.

The company, which is not the only drugmaker planning to file an appeal, said that patients will be stuck in limbo because of the lack of clarity it leaves for legal use of the drug, NBC News and Politico reported.

Roughly half of all abortions in the United States are performed using medications.

“Danco has been free to rely on procedures set by the FDA to distribute its product,” lawyers for the company said in a filing with the court.

“The Fifth Circuit’s decision immediately ends that,” the lawyers said. “A stay should issue to prevent the disruption and confusion that will result if the decision below were to remain operative.”

In addition to Danco, Politico reported that GenBioPro, which also manufactures the drug, has indicated that it will also file an appeal with the court.

Mifepristone was approved by the U.S. Food and Drug Administration in 2000 for medical termination of pregnancy and, until the COVID-19 pandemic, could only be prescribed during in-person appointments.

Early in the pandemic and the country locked down in an effort to stem the spread of the virus, doctors sued the FDA to allow them to prescribe mifepristone during telehealth visits.

The FDA temporarily changed the rule, but in 2023 adopted it permanently as some states started to restrict access to abortion and abortion services after the Supreme Court struck down Roe v. Wade.

Pharmaceutical companies and patient advocates warned that the restriction circumvents the FDA’s regulatory authority, which is based on evidence and data, and that it may offer a path for people to challenge other medications based on personal interest or opinion.

In the case of Danco, it also immediately filed the appeal because it is the only product it makes and “without a valid legal framework for distributing that product, Danco will lose its only source of revenue and may be unable to continue operating.”